|本期目录/Table of Contents|

[1]付 蔷,徐文贵,于筱舟,等.早期18F-FDG PET/CT显像在结直肠癌术后再分期中的临床价值[J].天津医科大学学报,2017,23(01):38-40.
 FU Qiang,XU Wen-gui,YU Xiao-zhou,et al.Value of early postoperative 18F-FDG PET/CT in restaging of the colorectal carcinoma[J].Journal of Tianjin Medical University,2017,23(01):38-40.
点击复制

早期18F-FDG PET/CT显像在结直肠癌术后再分期中的临床价值(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23卷
期数:
2017年01期
页码:
38-40
栏目:
临床医学
出版日期:
2017-01-16

文章信息/Info

Title:
Value of early postoperative 18F-FDG PET/CT in restaging of the colorectal carcinoma
文章编号:
1006-8147(2017)01-0038-03
作者:
付 蔷徐文贵于筱舟刘建井李小凤
(天津医科大学肿瘤医院分子影像与核医学诊疗科,国家肿瘤临床医学研究中心;天津市“肿瘤防治”重点实验室;天津市恶性肿瘤临床医学研究中心,天津 300060)
Author(s):
FU Qiang XU Wen-gui YU Xiao-zhouLIU Jian-jingLI Xiao-feng
(Department of Molecular Imaging and Nuclear Medicine, Cancer Institute and Hospital, Tianjin Medical University , National Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy ,Tianjins Clinical Research Center for China, Tianjin 300060, China)
关键词:
结直肠癌18F-FDG PET/CT显像再分期
Keywords:
colorectal carcinoma18F-FDG PET/CT restage
分类号:
R735.3
DOI:
-
文献标志码:
A
摘要:
目的:评价术后早期18F-FDG PET/CT显像在结直肠癌再分期中的临床价值。方法:回顾性分析术前分期明确后于本院行局部结直肠癌切除手术,并且行术后18F-FDG PET/CT显像的结直肠癌患者46例,根据显像结果对其进行再分期,分析分期改变率,并通过χ2检验和秩和检验分析再分期影响因素。结果:46例患者中共14例(30.4%)出现病理性18F-FDG 的摄取,其中13例证实为恶性病灶且分期上升,肝脏转移7例(53.8%),外周淋巴结转移5例(38.5%),腹膜转移1例(7.7%),意外发现其他类型肿瘤2例(15.4%),1例证实为淋巴结炎性反应性增生。PET/CT在诊断结直肠癌远处转移方面的灵敏度为100%,特异度为97.3%,阳性预测率为92.9%,阴性预测率为100%。秩和检验结果表明,相对于较早期I/II期结直肠癌病人而言,术后早期18F-FDG PET/CT显像对于晚期III期结直肠癌病人再分期改变率较高,χ2检验结果显示年龄、性别、原发部位对于术后再分期无显著影响。结论:术后早期18F-FDG PET/CT显像在结直肠癌再分期中具有重要的临床价值,尤其是对于晚期III期病人意义更为明显。
Abstract:
Objective: To evaluate 18F-FDG PET/CT in the diagnosis of restaging for colorectal carcinoma. Methods: Forty six cases, from Tumor Hospital of Tianjin Medical University, of postoperative colorectal carcinoma examined by 18F-FDG PET/CT imaging were reviewed to restage and analyze the influence factors by Chi-squared test and Kruskal-Wallis Test. Results: In all cases, pathological 18F-FDG uptake was observed in 14(30.4%). Of these,13 were upstaged with true-positive metastatic disease in distant organs after further workup liver in 7 cases, lymph node in 5 cases, peritoneum in one case) and one case had false-positive finding. The sensitivity and specificity of PET/CT for detecting metastatic disease were 100% and 97.3%, the positive predictive value was 92.9% and the negative predictive value was 100%.The Kruskal-Wallis univariate analysis showed that patients in stage III had more risk than the patients in stage I/II (P <0.05). The Chi-square test showed that age, sex and tumor location were not significantly associated with upstaging. Conclusion: The early postoperative 18F-FDG PET/CT have an important role in restaging of the colorectal carcinoma especially in the patients in stage III.

参考文献/References:

[1].Santos C, Lopez-Doriga A, Navarro M, et al. Clinicopathological risk factors of Stage II colon cncer :results of a prospective study[J]. Colorectal Dis, 2013,15(4):424
[2].[2] 中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会 中国结直肠癌诊疗规范(2015版)[J].中华消化外科杂志,2015,14(10):783
[3].[]Park I J, Kim H C, Yu C S, et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma[J]. Eur J Surg Oncol, 2006,32(9):941
[4].[4]周慧,胡宝华,饶敏,等. 脂肪对比剂灌肠多层螺旋CT对大肠癌分期的临床分析[J].实用放射学杂志,2008,(10):1378
[5].[5]于洪涛,赵铭,邢军,等.18F-FDG PET/CT在结直肠癌术后复发与转移诊断中 的应用价值与CEA水平关系的研究[J].中国肿瘤临床,2013,40(12):717
[6].[]Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008[J].CA Cancer J Clin,2008,58(2):71
[7].[7]Van C, Oliveira J, ESMO Guidelines Working Group. Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up[J].Ann Oncol,2009,20(supple 4):49
[8].[8]Van Cutsem E, Oliveira J, ESMO Guidelines Working Group. Advanced colorectal Cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up[J]. Ann Oncol,2009,20(supple 4):61
[9].[9]Vriens D, Geus-Oei G F, van der Graaf W T, et al. Tailoring therapy in colorectal Cancer by PET-CT[J].Q J Nucl Med Mol Imaging,2009, 53(2):224
[10].[10]Kantorová I, Lipská L, Bêlohlávek O, et al. Routine(18)F-FDG PET preoperativestaging of colorectal cancer: comparison with conventional staging and its impacton treatment decision making[J].J Nucl Med,2003,44(11):1784
[11].[11]Brush J, Boyd K, Chappell F, et al. The value of FDG positron emission Tomo-graphy/computerised tomography(PET/CT)in pre-operative staging of colorectal cancer:a systematic review and economic evaluation[J]. Health Technol Assess,2011,15(35):1
[12].[12]Brush J, Boyd K, Chappell F, et al. The Value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer:a systematic review and economic evaluation [J]. Health Technol Assess,2011,15(35):192
[13].[13]Flamen P, Hoekstra O S, Homans F, et al. Unexplained rising carcinoembryonic antigen(CEA)in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography(PET) [J]. Eur J Cancer,2001,37(7):862
[14].[14]Sobhani I, Tiret E, Lebtahi R, et al. Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer[J].Br J Cancer,2008,98(5):875
[15].[15]Wasserberg N, Purim O, Bard V, et al. Early postoperative 18F-FDG PET/CT in high-risk stage III colorectal cancer[J]. Clin Nucl Med,2015,40(4):e222
[16].[16]Simó M, Lomea F, Setoain J, et al. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer[J].Nucl Med Commun,2002,23(10):975

相似文献/References:

[1]吕文浩,王 吉,魏 颖,等.腹腔内脂肪面积和体质量指数对腹腔镜结直肠癌根治术及术后短期结局的影响[J].天津医科大学学报,2018,24(05):420.
 lv Wen-hao,WANG Ji,WEI Ying,et al.Impacts of intra-abdominal fat area and body mass index on laparoscopic surgery for colorectal cancer and short surgical outcomes[J].Journal of Tianjin Medical University,2018,24(01):420.
[2]万 音,程 曼,王梦影,等.膳食纤维肠内营养制剂对结直肠癌患者术后肠道屏障应激及营养指标的影响[J].天津医科大学学报,2019,25(02):105.
 WAN Yin,CHENG Man,WANG Meng-ying,et al.Effect of dietary fiber enteral nutrition preparation on postoperative intestinal barrier stress and nutritional index in patients with colorectal cancer[J].Journal of Tianjin Medical University,2019,25(01):105.
[3]贾朝阳,徐文贵,朱 磊,等.18F-FDG PET/CT在结直肠癌术后预后中的应用[J].天津医科大学学报,2019,25(04):342.
 JIA Zhao-yang,XU Wen-gui,ZHU Lei,et al.The application of 18F-FDG PET/CT in the prognosis of postoperative colorectal cancer[J].Journal of Tianjin Medical University,2019,25(01):342.
[4]李璐,李晓飞,孙悦,等.结直肠癌患者肠道菌群促进Apcmin/+小鼠肠道腺瘤进展的研究[J].天津医科大学学报,2019,25(06):551.
 LI Lu,LI Xiao-fei,SUN Yue,et al.Gut microbiota from patients with colorectal cancer promotes the progression of intestinal adenoma in Apcmin/+ mice[J].Journal of Tianjin Medical University,2019,25(01):551.
[5]孙冉,习贵富,赵楠,等.结直肠癌中PAQR3的表达水平及临床病理意义[J].天津医科大学学报,2023,29(06):582.
 SUN Ran,XI Gui-fu,ZHAO Nan,et al.The expression level and clinicopathologic significance of PAQR3 in colorectal cancer[J].Journal of Tianjin Medical University,2023,29(01):582.

备注/Memo

备注/Memo:

作者简介 付蔷(1991-),女,硕士在读,研究方向:肿瘤影像与核医学诊断;通信作者:徐文贵,E-mail: wenguixy@126.com。



?

更新日期/Last Update: 2017-01-16